Inhibition of hyaluronan is protective against renal ischaemia-reperfusion injury

Nephrology Dialysis Transplantation

Volumn 28, Issue 10, 2013, Pages 2484-2493

  Colombaro, Vanessa ^a   Declèves, Anne Emilie ^a,b   Jadot, Inès ^a   Voisin, Virginie ^a   Giordano, Laetitia ^a   Habsch, Isabelle ^a   Nonclercq, Denis ^c   Flamion, Bruno ^a   Caron, Nathalie ^a  

^a University of Namur   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF MONS   (Belgium)

Author keywords

acute kidney injury; fibrosis; hyaluronan; inflammation; ischaemia reperfusion

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CREATININE; HERMES ANTIGEN; HYALURONIC ACID; HYMECROMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARBOHYDRATE SYNTHESIS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; KIDNEY CORTEX; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY TUBULE; LEYDIG CELL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE KIDNEY INJURY; FIBROSIS; HYALURONAN; INFLAMMATION; ISCHAEMIA-REPERFUSION;

ACUTE KIDNEY INJURY; ANIMALS; DISEASE MODELS, ANIMAL; HYALURONIC ACID; HYMECROMONE; INDICATORS AND REAGENTS; INFLAMMATION; KIDNEY FUNCTION TESTS; MALE; MICE; MICE, INBRED C57BL; REPERFUSION INJURY;

EID: 84884945333     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft314     Document Type: Article

References (37)

1. Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997; 64: 945-957
2. Barri MY, Sanchez QE, Jennings WL et al. Acute kidney injury following liver transplantation: definition and outcome. Liver Transplant 2009; 15: 475-483
3. Bonventre VJ, Weinberg MJ. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210
4. Cruzado MJ, Torras J, Riera M et al. Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia. Am J Physiol Renal Physiol 2000; 279: 259-269
5. Forbes MJ, Hewitson DT, Becker JG et al. Ischemic acute renal failure: long term histology of cell and matrix changes in the rat. Kidney Int 2000; 57: 2375-2385
6. Bajwa A, Kinsey RG, Okusa DM. Immune mechanisms and novel pharmalogical therapies of acute kidney injury. Curr Drug Targets 2009; 10: 1196-1204
7. Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997; 242: 27-33 (Pubitemid 27323862)
8. Hansell P, Göransson V, Odlind C et al. Hyaluronan concentration in the kidney in different states of body hydration. Kidney Int 2000; 58: 2061-2068
9. Hällgren R, Gerdin B, Tufverson G. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. J Exp Med 1990; 171: 2063-2076
10. Campo MG, Avenoso A, Nastasi G et al. Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta 2011; 9: 1170-1181
11. Wells A, Larsson E, FellströmB et al. Role of hyaluronan in chronic and acutely rejecting kidneys. Transplant Proc 1993; 25: 2048-2049 (Pubitemid 23125201)
12. Johnsson C, Tufveson G, Wahlberg J et al. Experimentallyinduced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int 1996; 50: 1224-1229 (Pubitemid 26342813)
13. Declèves AE, Caron N, Nonclercq D et al. Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injury. Int J Mol Med 2006; 18: 83-94
14. Declèves AE, Caron N, Voisin V et al. Synthesis and fragmentation of hyaluronan in renal ischemia. Nephrol Dial Transplant 2012; 27: 3771-3781
15. Yamawaki H, Hirohata S, Miyoshi T et al. Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 2009; 19: 83-92
16. Han HD, Song KH, Lee YS et al. Upregulation of hyaluronan and its binding receptors in an experimental model of chronic cyclosporine nephropathy. Nephrology 2010; 15: 216-224
17. Jun Z, Hill AP, Lan YH et al. CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol 1997; 108: 69-77 (Pubitemid 27140333)
18. Rouschop MAK, Sewnath EM, Claessen N et al. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2004; 15: 674-686 (Pubitemid 38294797)
19. Rouschop MAK, Claessen N, Pals TS et al. CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-â1-induced apoptosis. J Am Soc Nephrol 2006; 17: 746-753
20. Kakizaki I, Kojima K, Takagaki K et al. A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 2004; 279: 33281-33289 (Pubitemid 39062975)
21. Yoshihara S, Kon A, Kudo D et al. A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells. FEBS Lett 2005; 579: 2722-2726 (Pubitemid 40615683)
22. Mochimaru H, Takahashi E, Tsukamoto N et al. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. IOVS 2009; 50: 4410-4415
23. Nagy N, Freudenberger T, Melchior-Becker A et al. Inhibition of hyaluronan synthesis accelerates murine atherosclerosis. Circulation 2010; 122: 2313-2322
24. Twarock S, Freudenberger T, Poscher E et al. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Mol Cancer 2011; 10: 1-14
25. Göransson V, Johnsson C, Jacobson A et al. Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia- reperfusion injury in the rat. Nephrol Dial Transplant 2004; 19: 823-830 (Pubitemid 38455652)
26. Asselman M, Verhulst A, Van Ballegooijen SE et al. Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 2005; 68: 71-83 (Pubitemid 43181365)
27. Ysebaert KD, De Greef EK, Vercauteren RS et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15: 1562-1574
28. Khan IA, Kerfoot MS, Heit B et al. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 2004; 173: 7594-7601 (Pubitemid 39628201)
29. Rouschop MAK, Roelofs JT, Claessen N et al. Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 2005; 16: 2034-2043 (Pubitemid 41716434)
30. Persy PV, Verhulst A, Ysebaert KD et al. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 2003; 63: 543-553 (Pubitemid 36126800)
31. Wüthrich PR. The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol Dial Transplant 1999; 14: 2554-2556
32. Ruffel B, Johnsson P. The regulation and function of hyaluronan binding by CD44 in the immune system. J. Immunol. 2008; 181: 7044-7054
33. Nickerson P, Jeffery J, Gough J et al. Identification of clinical and histopathological risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 1998; 9: 482-487 (Pubitemid 28122875)
34. Basile PD, Donohoe D, Roethe K et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: 887-899
35. Gehlhoff H, Semler P. Hymecromone in diseases of the bile ducts. Munch MedWochenschr 1978; 120: 741-742
36. Abate A, Dimartino V, Spina P et al. Hymercrome in the treatment of motor disorders of the bile ducts: a multicentre, doubleblind, placebo-controlled clinical study. Drugs Exp Clin Res 2001; 27: 223-231 (Pubitemid 34242053)
37. Goncharova V, Serobyan N, Iizuka S et al. Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis. J Biol Chem 2012; 287: 25419-25433